PRAX · Categories · Coverage
PRAX - Analyst coverage initiated
Praxis Precision Medicines Inc. (PRAX) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for PRAX
- Analyst initiated coverage on Praxis Precision Medicines with a new price targetAnalyst initiated coverage of Praxis Precision Medicines with a rating of Overweight and set a new price target of $700.00
- UBS initiated coverage on Praxis Precision Medicines with a new price targetUBS initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $706.00
- Goldman initiated coverage on Praxis Precision Medicines with a new price targetGoldman initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $447.00
- RBC Capital Mkts initiated coverage on Praxis Precision Medicines with a new price targetRBC Capital Mkts initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $449.00
- Raymond James initiated coverage on Praxis Precision Medicines with a new price targetRaymond James initiated coverage of Praxis Precision Medicines with a rating of Strong Buy and set a new price target of $815.00
- Wolfe Research initiated coverage on Praxis Precision Medicines with a new price targetWolfe Research initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $500.00
- Wells Fargo initiated coverage on Praxis Precision Medicines with a new price targetWells Fargo initiated coverage of Praxis Precision Medicines with a rating of Equal Weight and set a new price target of $282.00
- BTIG Research initiated coverage on Praxis Precision Medicines with a new price targetBTIG Research initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $424.00
- Chardan Capital Markets initiated coverage on Praxis Precision Medicines with a new price targetChardan Capital Markets initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $80.00
- Deutsche Bank initiated coverage on Praxis Precision Medicines with a new price targetDeutsche Bank initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $111.00
- Oppenheimer initiated coverage on Praxis Precision Medicines with a new price targetOppenheimer initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $134.00
- Needham initiated coverage on Praxis Precision Medicines with a new price targetNeedham initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $145.00
- Guggenheim initiated coverage on Praxis Precision Medicines with a new price targetGuggenheim initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $155.00
- Robert W. Baird initiated coverage on Praxis Precision Medicines with a new price targetRobert W. Baird initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $117.00
- Truist initiated coverage on Praxis Precision Medicines with a new price targetTruist initiated coverage of Praxis Precision Medicines with a rating of Buy and set a new price target of $10.00
- HC Wainwright & Co. initiated coverage on Praxis Precision Medicine with a new price targetHC Wainwright & Co. initiated coverage of Praxis Precision Medicine with a rating of Buy and set a new price target of $48.00
- B of A Securities initiated coverage on Praxis Precision Medicine with a new price targetB of A Securities initiated coverage of Praxis Precision Medicine with a rating of Buy and set a new price target of $28.00
- William Blair initiated coverage on Praxis Precision MedicineWilliam Blair initiated coverage of Praxis Precision Medicine with a rating of Outperform